The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nanotechnology for Healthcare Market Research Report 2024
Synopsis
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 102 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
The global Nanotechnology for Healthcare market was valued at US$ 227160 million in 2023 and is anticipated to reach US$ 460360 million by 2030, witnessing a CAGR of 10.8% during the forecast period 2024-2030.
The nanotechnology for healthcare market is driven by its potential to revolutionize medical diagnosis, treatment, and drug delivery through precise targeting at the nanoscale level. Nanotechnology enables the development of innovative therapies, such as nanoparticles for drug delivery and nanosensors for early disease detection, promising enhanced treatment outcomes and reduced side effects. However, there are challenges to address, including concerns about the safety and toxicity of nanoparticles, regulatory hurdles, and the high cost of research and development. Ensuring the safe and responsible use of nanotechnology in healthcare, along with comprehensive regulations, will be vital to harness its full potential. Additionally, collaborations between researchers, healthcare professionals, and regulatory bodies will play a crucial role in overcoming these challenges and advancing the field of nanotechnology in healthcare.
This report aims to provide a comprehensive presentation of the global market for Nanotechnology for Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology for Healthcare.
Report Scope
The Nanotechnology for Healthcare market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanotechnology for Healthcare market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanotechnology for Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Bristol-Myers Squibb
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Kirin
Servier Pharmaceuticals
Ipsen
Endo International
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanotechnology for Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 102 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
The global Nanotechnology for Healthcare market was valued at US$ 227160 million in 2023 and is anticipated to reach US$ 460360 million by 2030, witnessing a CAGR of 10.8% during the forecast period 2024-2030.
The nanotechnology for healthcare market is driven by its potential to revolutionize medical diagnosis, treatment, and drug delivery through precise targeting at the nanoscale level. Nanotechnology enables the development of innovative therapies, such as nanoparticles for drug delivery and nanosensors for early disease detection, promising enhanced treatment outcomes and reduced side effects. However, there are challenges to address, including concerns about the safety and toxicity of nanoparticles, regulatory hurdles, and the high cost of research and development. Ensuring the safe and responsible use of nanotechnology in healthcare, along with comprehensive regulations, will be vital to harness its full potential. Additionally, collaborations between researchers, healthcare professionals, and regulatory bodies will play a crucial role in overcoming these challenges and advancing the field of nanotechnology in healthcare.
This report aims to provide a comprehensive presentation of the global market for Nanotechnology for Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology for Healthcare.
Report Scope
The Nanotechnology for Healthcare market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanotechnology for Healthcare market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanotechnology for Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Bristol-Myers Squibb
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Kirin
Servier Pharmaceuticals
Ipsen
Endo International
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanotechnology for Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanotechnology for Healthcare Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nanotechnology for Healthcare Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanotechnology for Healthcare Market Perspective (2019-2030)
2.2 Nanotechnology for Healthcare Growth Trends by Region
2.2.1 Global Nanotechnology for Healthcare Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanotechnology for Healthcare Historic Market Size by Region (2019-2024)
2.2.3 Nanotechnology for Healthcare Forecasted Market Size by Region (2025-2030)
2.3 Nanotechnology for Healthcare Market Dynamics
2.3.1 Nanotechnology for Healthcare Industry Trends
2.3.2 Nanotechnology for Healthcare Market Drivers
2.3.3 Nanotechnology for Healthcare Market Challenges
2.3.4 Nanotechnology for Healthcare Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology for Healthcare Players by Revenue
3.1.1 Global Top Nanotechnology for Healthcare Players by Revenue (2019-2024)
3.1.2 Global Nanotechnology for Healthcare Revenue Market Share by Players (2019-2024)
3.2 Global Nanotechnology for Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanotechnology for Healthcare Revenue
3.4 Global Nanotechnology for Healthcare Market Concentration Ratio
3.4.1 Global Nanotechnology for Healthcare Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology for Healthcare Revenue in 2023
3.5 Nanotechnology for Healthcare Key Players Head office and Area Served
3.6 Key Players Nanotechnology for Healthcare Product Solution and Service
3.7 Date of Enter into Nanotechnology for Healthcare Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanotechnology for Healthcare Breakdown Data by Type
4.1 Global Nanotechnology for Healthcare Historic Market Size by Type (2019-2024)
4.2 Global Nanotechnology for Healthcare Forecasted Market Size by Type (2025-2030)
5 Nanotechnology for Healthcare Breakdown Data by Application
5.1 Global Nanotechnology for Healthcare Historic Market Size by Application (2019-2024)
5.2 Global Nanotechnology for Healthcare Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nanotechnology for Healthcare Market Size (2019-2030)
6.2 North America Nanotechnology for Healthcare Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanotechnology for Healthcare Market Size by Country (2019-2024)
6.4 North America Nanotechnology for Healthcare Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanotechnology for Healthcare Market Size (2019-2030)
7.2 Europe Nanotechnology for Healthcare Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanotechnology for Healthcare Market Size by Country (2019-2024)
7.4 Europe Nanotechnology for Healthcare Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology for Healthcare Market Size (2019-2030)
8.2 Asia-Pacific Nanotechnology for Healthcare Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanotechnology for Healthcare Market Size by Region (2019-2024)
8.4 Asia-Pacific Nanotechnology for Healthcare Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanotechnology for Healthcare Market Size (2019-2030)
9.2 Latin America Nanotechnology for Healthcare Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanotechnology for Healthcare Market Size by Country (2019-2024)
9.4 Latin America Nanotechnology for Healthcare Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology for Healthcare Market Size (2019-2030)
10.2 Middle East & Africa Nanotechnology for Healthcare Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanotechnology for Healthcare Market Size by Country (2019-2024)
10.4 Middle East & Africa Nanotechnology for Healthcare Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Nanotechnology for Healthcare Introduction
11.1.4 Amgen Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Detail
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Nanotechnology for Healthcare Introduction
11.2.4 Teva Pharmaceuticals Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Nanotechnology for Healthcare Introduction
11.3.4 Abbott Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 UCB
11.4.1 UCB Company Detail
11.4.2 UCB Business Overview
11.4.3 UCB Nanotechnology for Healthcare Introduction
11.4.4 UCB Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Nanotechnology for Healthcare Introduction
11.5.4 Roche Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Nanotechnology for Healthcare Introduction
11.6.4 Bristol-Myers Squibb Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Nanotechnology for Healthcare Introduction
11.7.4 Sanofi Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Detail
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Nanotechnology for Healthcare Introduction
11.8.4 Merck & Co Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.8.5 Merck & Co Recent Development
11.9 Biogen
11.9.1 Biogen Company Detail
11.9.2 Biogen Business Overview
11.9.3 Biogen Nanotechnology for Healthcare Introduction
11.9.4 Biogen Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.9.5 Biogen Recent Development
11.10 Stryker
11.10.1 Stryker Company Detail
11.10.2 Stryker Business Overview
11.10.3 Stryker Nanotechnology for Healthcare Introduction
11.10.4 Stryker Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.10.5 Stryker Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Detail
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Nanotechnology for Healthcare Introduction
11.11.4 Gilead Sciences Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.11.5 Gilead Sciences Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Nanotechnology for Healthcare Introduction
11.12.4 Pfizer Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.12.5 Pfizer Recent Development
11.13 3M Company
11.13.1 3M Company Company Detail
11.13.2 3M Company Business Overview
11.13.3 3M Company Nanotechnology for Healthcare Introduction
11.13.4 3M Company Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.13.5 3M Company Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Detail
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Nanotechnology for Healthcare Introduction
11.14.4 Johnson & Johnson Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.14.5 Johnson & Johnson Recent Development
11.15 Smith & Nephew
11.15.1 Smith & Nephew Company Detail
11.15.2 Smith & Nephew Business Overview
11.15.3 Smith & Nephew Nanotechnology for Healthcare Introduction
11.15.4 Smith & Nephew Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.15.5 Smith & Nephew Recent Development
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Detail
11.16.2 Leadiant Biosciences Business Overview
11.16.3 Leadiant Biosciences Nanotechnology for Healthcare Introduction
11.16.4 Leadiant Biosciences Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.16.5 Leadiant Biosciences Recent Development
11.17 Kyowa Kirin
11.17.1 Kyowa Kirin Company Detail
11.17.2 Kyowa Kirin Business Overview
11.17.3 Kyowa Kirin Nanotechnology for Healthcare Introduction
11.17.4 Kyowa Kirin Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.17.5 Kyowa Kirin Recent Development
11.18 Servier Pharmaceuticals
11.18.1 Servier Pharmaceuticals Company Detail
11.18.2 Servier Pharmaceuticals Business Overview
11.18.3 Servier Pharmaceuticals Nanotechnology for Healthcare Introduction
11.18.4 Servier Pharmaceuticals Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.18.5 Servier Pharmaceuticals Recent Development
11.19 Ipsen
11.19.1 Ipsen Company Detail
11.19.2 Ipsen Business Overview
11.19.3 Ipsen Nanotechnology for Healthcare Introduction
11.19.4 Ipsen Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.19.5 Ipsen Recent Development
11.20 Endo International
11.20.1 Endo International Company Detail
11.20.2 Endo International Business Overview
11.20.3 Endo International Nanotechnology for Healthcare Introduction
11.20.4 Endo International Revenue in Nanotechnology for Healthcare Business (2019-2024)
11.20.5 Endo International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
